These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735 [TBL] [Abstract][Full Text] [Related]
3. Synthetic polymers. van Beusekom HM; Schwartz RS; van der Giessen WJ Semin Interv Cardiol; 1998; 3(3-4):145-8. PubMed ID: 10406684 [TBL] [Abstract][Full Text] [Related]
4. [Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention]. Siminiak T Kardiol Pol; 2010 May; 68(5):510-1. PubMed ID: 20491009 [No Abstract] [Full Text] [Related]
5. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating. Jabara R; Chronos N; Robinson K Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model. Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization. Liuzzo JP; Ambrose JA; Coppola JT J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242 [TBL] [Abstract][Full Text] [Related]
9. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559 [TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model. Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137 [TBL] [Abstract][Full Text] [Related]
11. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302 [TBL] [Abstract][Full Text] [Related]
12. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311 [TBL] [Abstract][Full Text] [Related]
13. Endovascular stent configuration affects intraluminal flow dynamics and in vitro endothelialization. Akagawa E; Ookawa K; Ohshima N Biorheology; 2004; 41(6):665-80. PubMed ID: 15851843 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Carter AJ; Aggarwal M; Kopia GA; Tio F; Tsao PS; Kolata R; Yeung AC; Llanos G; Dooley J; Falotico R Cardiovasc Res; 2004 Sep; 63(4):617-24. PubMed ID: 15306217 [TBL] [Abstract][Full Text] [Related]
15. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model. Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441 [TBL] [Abstract][Full Text] [Related]
18. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model. Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906 [TBL] [Abstract][Full Text] [Related]
19. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: optical coherence tomography findings. Takano M; Jang IK; Mizuno K Eur Heart J; 2006 Aug; 27(15):1763. PubMed ID: 16476695 [No Abstract] [Full Text] [Related]
20. Experimental efficacy of an everolimus eluting cobalt chromium stent. Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]